Peptide Antibiotics: A Leading Driver Behind Rising Prevalence Of Infectious Diseases Fuels Peptide Antibiotics Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Peptide Antibiotics Industry Market Size Be by 2025?
The market size of peptide antibiotics has seen a substantial increase in recent years. It's predicted to expand from $5.25 billion in 2024 to $5.77 billion in 2025 with a compound annual growth rate (CAGR) of 9.8%. The historic growth can be accredited to several factors such as the discovery and promotion of peptide antibiotics, a higher resistance to antibiotics, a surge in the occurrence of infectious diseases, advancement in peptide synthesis technologies, and the expansion of the pharmaceutical industry.

What's the Long-Term Growth Forecast for the Peptide Antibiotics Market Size Through 2029?
The market size of peptide antibiotics is anticipated to experience significant growth in the coming years, reaching "$8.29 billion in 2029 with a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth in the predicted period include a focus on the development of innovative antibiotics, a rise in global antibiotic-resistant infections, an increase in research and development activities related to antimicrobial peptides, and regulatory encouragement for new antibiotic sanctions. The forecast period will also observe major trends such as examining natural resources for antimicrobial peptides, the application of peptide antibiotics in animal healthcare, focus on peptide engineering to enhance effectiveness, development of mixed peptide antibiotics, and implementation of artificial intelligence and machine learning in the discovery of peptide antibiotics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

What Are the Key Growth Drivers Fueling the Peptide Antibiotics Market Expansion?
The upsurge in various infectious diseases prevalence is anticipated to boost the peptide antibiotics market's growth. Infectious diseases, sourced by detrimental microorganisms such as bacteria, fungi, parasites, among others, are on the rise due to rapid urbanization, climate change, an increasing risk of disease emergence and alike. These conditions have surged the demand for peptide antibiotics, which function by rupturing physical cell membranes, thereby enhancing antibacterial activity. A case in point - the World Health Organization, an intergovernmental organization based in Switzerland, reported an over seven million surge in dengue cases in America region by April 2024, which substantially exceeded 4.6 million total cases in 2023. Hence, the heightened incidence of infectious diseases substantiates the growth of the peptide antibiotics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

Which Emerging Trends Are Transforming the Peptide Antibiotics Market in 2025?
A rising trend in the peptide antibiotics market is the formation of strategic alliances, with major industry players increasingly engaging in such partnerships to advance their market presence and mutually benefit from shared resources. This trend was exemplified in January 2022 when US digital cell biology firm Berkeley Lights teamed up with Aanika Biosciences. This collaboration will allow Aanika to utilize Berkeley Lights' rapid and high-capacity functional screening service for precise detection and enhancement of antimicrobial peptides (AMPs); these specific peptides can eradicate harmful bacteria, especially those causing foodborne diseases. Additionally, the Beacon Optofluidic Platform will aid in recognizing bacteria-damaging peptides to create an innovative antibacterial tag. This tag will be incorporated into their bacterial spore-based barcoding technology, thus ensuring food supply chain safety. Aanika Biosciences is a biotech firm based in the USA.

How Is the Peptide Antibiotics Market Segmented?
The peptide antibiotics market covered in this report is segmented -

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp

Which Companies Are Leading the Charge in Peptide Antibiotics Market Innovation?
Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

Which Regions Are Leading the Global Peptide Antibiotics Market in Revenue?
North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.